LG

Laxay Garg

Active Director Director DIN 06840995
DIN 06840995 First appointment Aug 2017 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2017
Shareholding value •••• Premium profile

About Laxay Garg

Data last updated:

Laxay Garg is a Director at Pansofi Biotech Private Limited (since 2017). The company operates in Trading. Pansofi Biotech Private Limited reported revenue of ₹1.4 Lakh (FY 2025).

DIN 06840995
Primary Designation Director
Industry Trading
First Appointment 22 Aug 2017
Oldest Company Age 9 yrs
Largest company Pansofi Biotech Private Limited · ₹1.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pansofi Biotech Private Limited U51909HR2017PTC070427
Director22 Aug 20172017₹1.4 Lakh (FY 2025)Active

Board colleagues of Laxay Garg

NameDINCompanyDesignation
Sumit Garg06840593Pansofi Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Pansofi Biotech Private Limited
Premium access

Shareholding and investment profile for Laxay Garg

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Laxay Garg

Laxay Garg currently holds 1 directorship: Pansofi Biotech Private Limited (Director, since 22 Aug 2017, revenue ₹1.4 Lakh (FY 2025)).

Laxay Garg was first appointed on 22 Aug 2017 as Director at Pansofi Biotech Private Limited.

The current boards of Laxay Garg's companies include Sumit Garg (Pansofi Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available